Bill Text: NY A08932 | 2019-2020 | General Assembly | Introduced

New York Assembly Bill 8932 (Prior Session Legislation)

Introduced

Bill Title: Relates to designating an individual to be notified in the case of dose or brand change for psychotropic medication.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2020-01-08 - referred to health [A08932 Detail]

Download: New_York-2019-A08932-Introduced.html




                STATE OF NEW YORK
        ________________________________________________________________________

                                          8932

                   IN ASSEMBLY

                                     January 2, 2020
                                       ___________

        Introduced  by M. of A. BARCLAY -- read once and referred to the Commit-
          tee on Health

        AN ACT to amend the public health law, in  relation  to  designating  an
          individual  to  be  notified  in  the case of dose or brand change for
          psychotropic medication

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section 1. Subdivision 3 of section 2803-c of the public health law is
     2  amended by adding a new paragraph r to read as follows:
     3    r.  (i) Pursuant to regulations promulgated by the commissioner, every
     4  patient shall have the right to designate an individual to  be  notified
     5  in  the event that the facility reduces the dose or changes the brand or
     6  form of the patient's psychotropic medication. Such  notification  shall
     7  include  a  warning listing possible side effects and drug interactions,
     8  including side effects upon discontinuation of such drugs.  Notification
     9  shall  be  made  in writing, and shall not be effective until receipt of
    10  the written consent of the designated individual. In the case of a grad-
    11  ual dose reduction, a designee shall  check  a  box  acknowledging  such
    12  designee  has been given a copy of the rights pertaining to gradual dose
    13  reductions.
    14    (ii) For the purposes of  this  paragraph,  "psychotropic  medication"
    15  means  a  medication  that  is administered for the purpose of affecting
    16  brain activities associated with mental processes and behavior,  includ-
    17  ing, but not limited to, anti-psychotics, anti-depressants, anxiolytics,
    18  sedatives and hypnotics.
    19    § 2. This act shall take effect on the one hundred eightieth day after
    20  it shall have become a law.



         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD14049-03-9